In parallel, Safa et al. explored the involvement of lncRNAs associated with the NF-κB signaling in MS and identified MKI67IP and HNF1A-AS1 as key inhibitors of this pathway. This evidence concerns the gene NFKB1 and myeloid sarcoma.